Strategic Partnerships There are active partnerships with Awakn Life Sciences and Relationship Resources, suggesting opportunities to co-market psychedelic wellness protocols and exclusive treatment offerings to complementary patient segments.

Expanding Access Current clinic footprint in New York City, Rockland County, and Miami indicates growth potential in major metro areas; sales outreach could target corporate wellness programs and insurance backbones to scale access.

Clinical Programs Medically supervised ketamine IVs and Spravato indicate a focus on evidence-based psychedelic treatments; sales can position to larger health systems or clinics seeking to augment their psychiatric offerings with managed psychedelic services.

Financial Readiness Revenue range of one to ten million suggests mid-market scale with room for expansion; potential clients include mid-sized clinics or networks seeking scalable partnerships, licensing, or white-label services.

Market Positioning Active involvement in psychedelic therapy space with notable press coverage and high-profile collaborations signals credibility; use this to approach health plans, employers, and research partners seeking validated programs.